Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Azygos Anterior Cerebral Artery Occlusion Presenting with Acute Paraparesis: A Myelopathy Mimic

Author:Chionatos, Rafail   Valhuerdi Porto, Camelia   Srinivasan, Nikita   Bareja, Naman   Bahadori, Maryam   Scott, Lisa   Yakhkind, Aleksandra   

Session Name:P8: Cerebrovascular Disease and Interventional Neurology: Neurovascular Conditions and Rare Strokes Etiologies 2  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P8.002  

Author Institution:Tufts Medical Center, Boston, MA  Tufts Medical Center, Weston, MA  Keck School of Medicine University of Southern California, Los Angeles, CA  

May-Thurner Syndrome Presenting as Recurrent Embolic Stroke of Undetermined Source Associated with a Low Risk of Paradoxical Embolism Score

Author:Hadaway, Angel   Moreno-Zambrano, Daniel   Labrada, Ariol   Sanchez, Roberto   

Session Name:P8: Cerebrovascular Disease and Interventional Neurology: Educational Cases and Systematic Reviews  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P8.002  

Author Institution:Larkin Community Hospital, Miami, FL  Larkin Community Hospital , Miami, FL  Palmetto General Hospital , Doral, FL  Palmetto General Hospital , Miami, FL  

Development of a Novel Patient-reported Outcome Measure of Functional Impacts for Narcolepsy Types 1 and 2

Author:Romero, Heather   Savva, Yulia   Crawford, Stephen   McPherson, Peter   Doll, Helen   Howerter, Amy   Symonds, Tara   Swick, Todd   Dauvilliers, Yves   

Session Name:P8: Sleep 2  

Topic:Sleep  

Program Number:P8.003  

Author Institution:Takeda Development Center Americas, Inc., Cambridge, MA  Clinical Outcomes Solutions, Folkstone, United Kingdom  Clinical Outcomes Solutions, Tuscon, AZ  Sleep-Wake Disorders Center, Department of Neurology, Gui-de-Chauliac Hospital, University of Montpelier, Montpellier, France  

Long-term Function and Survival of Radicava ORS® (Oral Edaravone)-Treated Patients With ALS vs Propensity Score–Matched PRO-ACT Historical Controls

Author:Takahashi, Fumihiro   Genge, Angela   Yoneoka, Takatomo   Hirai, Manabu   Selness, Daniel   Todorovic, Vesna   Wamil, Art   Sasson, Nissim   Apple, Stephen   Yoshiteru, Ushirogawa   

Session Name:P8: General Neurology: Motor Neuron Disease 1  

Topic:General Neurology  

Program Number:P8.003  

Author Institution:Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  Montreal Neurological Institute and Hospital, Montreal, QC, Canada  Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan  Mitsubishi Tanabe Pharma Europe, Ltd, London, United Kingdom  NStat Solutions, Biostatistical Services, Rehovot, Israel  

First-in-Human Trial of NRTX-1001 GABAergic Interneuron Cell Therapy for Focal Epilepsy - Updated Clinical Trial Results

Author:Hixson, John   Spencer, David   Burchiel, Kim   Babu, Harish   Beach, Robert   Shih, Jerry   Ben-Haim, Sharona   O'Dwyer, Rebecca   Sani, Sepehr   Southwell, Derek   Luedke, Matthew   Blum, David   Banik, Gautam   Bershteyn, Marina   Bulfone, Alessandro   Feld, Brianna   Finefrock, Holl   

Session Name:P8: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Clinical Trials  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P8.003  

Author Institution:Neurona Therapeutics, South San Francisco, CA  OHSU, Portland, OR  SUNY Syracuse, Syracuse, NY  UC San Diego Health, La Jolla, CA  Rush University Medical Center, Chicago, IL  Duke University, Durham, NC  Duke University Hospital Dept. of Neurology, Durham, NC  Neurona Therapeutics, Santa Barbara, CA  Neurona Therapeutics, Redwood City, CA  Neurona Therapeutics, Menlo Park, CA